175 related articles for article (PubMed ID: 22553935)
1. Clinical features and prognostic model for extranasal NK/T-cell lymphoma.
Jo JC; Yoon DH; Kim S; Lee BJ; Jang YJ; Park CS; Huh J; Lee SW; Ryu JS; Suh C
Eur J Haematol; 2012 Aug; 89(2):103-10. PubMed ID: 22553935
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
3. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Yamaguchi M; Suzuki R; Miyazaki K; Amaki J; Takizawa J; Sekiguchi N; Kinoshita S; Tomita N; Wada H; Kobayashi Y; Niitsu N; Ando T; Maeda T; Saito B; Matsuoka H; Sakai R; Kubota N; Masaki Y; Kameoka Y; Asano N; Oguchi M; Katayama N
Ann Hematol; 2019 Jul; 98(7):1647-1655. PubMed ID: 31001658
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
[TBL] [Abstract][Full Text] [Related]
5. Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.
Yamazaki E; Tomita N; Koyama S; Ogusa E; Ishii Y; Takahashi H; Miyashita K; Matsuura S; Tachibana T; Takasaki H; Takemura S; Fujimaki K; Sakai R; Fujisawa S; Ishigatsubo Y
Med Oncol; 2014 Sep; 31(9):149. PubMed ID: 25108598
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Bai B; Huang HQ; Cai QC; Fan W; Wang XX; Zhang X; Lin ZX; Gao Y; Xia YF; Guo Y; Cai QQ; Jiang WQ; Lin TY
Med Oncol; 2013 Mar; 30(1):339. PubMed ID: 23329306
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.
Huang JJ; Li YJ; Xia Y; Wang Y; Wei WX; Zhu YJ; Lin TY; Huang HQ; Jiang WQ; Li ZM
BMC Cancer; 2013 May; 13():222. PubMed ID: 23638998
[TBL] [Abstract][Full Text] [Related]
8. The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Jiang WQ; Huang JJ; Xia ZJ; Huang HQ; Li ZM
Am J Hematol; 2013 May; 88(5):394-9. PubMed ID: 23423859
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
10. Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Yamaguchi M; Suzuki R; Oguchi M; Asano N; Amaki J; Akiba T; Maeda T; Itasaka S; Kubota N; Saito Y; Kobayashi Y; Itami J; Ueda K; Miyazaki K; Ii N; Tomita N; Sekiguchi N; Takizawa J; Saito B; Murayama T; Ando T; Wada H; Hyo R; Ejima Y; Hasegawa M; Katayama N
J Clin Oncol; 2017 Jan; 35(1):32-39. PubMed ID: 28034070
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Characteristics and Prognostic Analysis of Extranodal NK/T-Cell Lymphoma Patients Treated with Pegaspargase Based Chemotherapy].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):735-740. PubMed ID: 34105466
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Nomogram for Overall Survival in Early Stage Extranodal Natural Killer/T Cell Lymphoma Treated With High-Dose Radiotherapy.
Huang L; Wu Y; Wang Y; Xie Y; Wu F; Li S; Liang Z; Zhu X
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):289-295. PubMed ID: 32122775
[TBL] [Abstract][Full Text] [Related]
13. The clinical study of extranodal natural killer cell lymphoma, nasal type.
Gui W; Zhao Z; Shen Q; Wang T; Yang B; He J; Li X; Hou S; Zhang L; Zhang Q; Su L
Med Oncol; 2011 Dec; 28 Suppl 1():S367-72. PubMed ID: 21128014
[TBL] [Abstract][Full Text] [Related]
14. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
16. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
Wang X; Hu J; Dong M; Ding M; Zhu L; Wu J; Sun Z; Li X; Zhang L; Li L; Wang X; Fu X; Wang G; Chen Q; Zhang M; Zhang X
Clin Transl Sci; 2021 Jan; 14(1):405-411. PubMed ID: 33045134
[TBL] [Abstract][Full Text] [Related]
17. Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.
Wang YQ; Yang Y; Zhuo HY; Zou LQ; Jiang Y; Jiang M
Med Oncol; 2015 Feb; 32(2):435. PubMed ID: 25572807
[TBL] [Abstract][Full Text] [Related]
18. Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India.
Shet T; Suryawanshi P; Epari S; Sengar M; Rangarajan V; Menon H; Laskar S
Leuk Lymphoma; 2014 Dec; 55(12):2748-53. PubMed ID: 24597982
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
20. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
